Trial Profile
Evaluation of the tubular effects of dapagliflozin using 1HNMR spectroscopy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Chlortalidone (Primary) ; Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 17 Apr 2019 Status changed from recruiting to completed.
- 28 Nov 2018 This trial has been completed in Greece, according to European Clinical Trials Database.
- 24 Oct 2017 Status changed from active, no longer recruiting to recruiting.